26 results
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
25 Apr 24
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
9:00am
recognition of our product’s quality and safety standards. We believe, subject to U.S. Food and Drug Administration (FDA) regulatory clearance … and certification to evaluate compliance with safety and performance requirements defined by the CSA.
The Certification of Compliance allows
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
25 Oct 23
Inspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical Device
7:48am
patient safety with a proprietary built-in self-automated priming module aimed to ensure an emboli-free connection to the patient’s vascular system
6-K
EX-1.1
je5k gq0v2o
4 Apr 23
Report of Foreign Private Issuer
4:21pm
6-K
EX-99.1
lwuk01ld
23 Nov 22
Inspira™ Technologies Reports Third Quarter 2022 Financial Results
4:01pm
6-K
EX-99.1
b35ozs5wfnuc j8ndqm
10 Nov 22
InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System
8:40am
6-K
nyw 1gqp8b
10 Nov 22
InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System
8:40am
20-F
gzqo 2zz6t
31 Mar 22
Annual report (foreign)
4:48pm
6-K
EX-99.1
mfl5k2ezs r1od
6 Jan 22
Report of Foreign Private Issuer
6:47am
POS AM
tu2ghfz wiuq
27 Oct 21
Prospectus update (post-effective amendment)
9:17am
424B4
f9tflda
15 Jul 21
Prospectus supplement with pricing info
4:06pm
F-1/A
mk8z0dp3h6 m5wh3dxti
1 Jul 21
Registration statement (foreign) (amended)
11:58am
F-1/A
kcjlheue r4qq0
28 Jun 21
Registration statement (foreign) (amended)
11:41am
F-1/A
h5l3bi
8 Jun 21
Registration statement (foreign) (amended)
5:26pm
F-1/A
EX-1.1
q0besjswl6ssr2j32c
8 Jun 21
Registration statement (foreign) (amended)
5:26pm
FWP
puoci
29 Mar 21
Free writing prospectus
5:22pm
F-1/A
pgt4jimaaubbojb4hw
29 Mar 21
Registration statement (foreign) (amended)
5:19pm